Matches in Wikidata for { <http://www.wikidata.org/entity/Q99569495> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q99569495 description "article scientifique publié en 2020" @default.
- Q99569495 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99569495 description "scientific article published on 06 September 2020" @default.
- Q99569495 description "wetenschappelijk artikel" @default.
- Q99569495 description "наукова стаття, опублікована 6 вересня 2020" @default.
- Q99569495 name "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 name "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 type Item @default.
- Q99569495 label "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 label "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 prefLabel "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 prefLabel "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 P1433 Q99569495-6F57FB34-3C77-4B37-A33C-C88EED93650D @default.
- Q99569495 P1476 Q99569495-11123B07-BA3F-4968-9490-723206721627 @default.
- Q99569495 P2093 Q99569495-14E5CEEC-B257-4B19-90FD-1EE205A902CA @default.
- Q99569495 P2093 Q99569495-24FD89FC-67D5-4202-A331-2011A2777E42 @default.
- Q99569495 P2093 Q99569495-2CFE640E-6BC4-4A5F-A349-28479D5B316A @default.
- Q99569495 P2093 Q99569495-80431083-CCD7-4320-801C-71E21A7CA8DE @default.
- Q99569495 P2093 Q99569495-A58CBD53-FAF5-4F83-8FC1-7554D01E44AF @default.
- Q99569495 P2093 Q99569495-BC7FB1C8-71E5-472F-9B84-AC16DB75D385 @default.
- Q99569495 P304 Q99569495-DCAD449F-385B-4219-A026-538B023487B1 @default.
- Q99569495 P31 Q99569495-A61180D3-D3C3-42E7-B085-274327A57BD8 @default.
- Q99569495 P356 Q99569495-28E26B67-A11F-43CE-8D55-9FEBA165C348 @default.
- Q99569495 P478 Q99569495-455AC9C3-540B-475D-A282-56E3CCBB74BD @default.
- Q99569495 P577 Q99569495-26B4FFBE-1F49-4712-8D35-0314D857A696 @default.
- Q99569495 P698 Q99569495-224DE41A-78C4-4A5E-8E70-B2D9BA165F3D @default.
- Q99569495 P921 Q99569495-F2B0E132-914E-40EE-AE5E-88D3B9DE05A7 @default.
- Q99569495 P356 J.THROMRES.2020.09.002 @default.
- Q99569495 P698 32947066 @default.
- Q99569495 P1433 Q15758741 @default.
- Q99569495 P1476 "Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system" @default.
- Q99569495 P2093 "Ashley Dinh" @default.
- Q99569495 P2093 "Eric Salazar" @default.
- Q99569495 P2093 "Kevin R Donahue" @default.
- Q99569495 P2093 "Melanie Ruegger" @default.
- Q99569495 P2093 "Nicholas Jakowenko" @default.
- Q99569495 P2093 "Steffany Nguyen" @default.
- Q99569495 P304 "276-282" @default.
- Q99569495 P31 Q13442814 @default.
- Q99569495 P356 "10.1016/J.THROMRES.2020.09.002" @default.
- Q99569495 P478 "196" @default.
- Q99569495 P577 "2020-09-06T00:00:00Z" @default.
- Q99569495 P698 "32947066" @default.
- Q99569495 P921 Q414462 @default.